HDL metabolism in hypertriglyceridemic states: an overview.
about
Low fasting low high-density lipoprotein and postprandial lipemiaOrigin and therapy for hypertriglyceridaemia in type 2 diabetesAmyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosisFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewHigh density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).Proprotein convertases in high-density lipoprotein metabolism.Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study.Alcohol, nutrition and health maintenance: selected aspects.Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women.Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.HDL dysfunction in diabetes: causes and possible treatments.Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects.Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.Toxic metabolic syndrome associated with HAART.Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study.Plasma lipid transfer enzymes in non-diabetic lean and obese men and womenUnraveling the complexities of the HDL lipidomeMitotane-induced hyperlipidemia: a retrospective cohort study.Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.Effects of simvastatin 20 mg/d on serum lipid profiles in Japanese hyperlipidemic patients: A prospective, open-label pilot study.Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies.High-density lipoprotein: what is the best way to measure its antiatherogenic potential?Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural InsightsFamilial aggregation of metabolic syndrome indicators in Portuguese families.The Effect of Residing Altitude on Levels of High-Density Lipoprotein Cholesterol: A Pilot Study From the Omani Arab Population.Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women.Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.New model for kinetic studies of HDL metabolism in humans.Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism.Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.Effect of exercise timing on postprandial lipemia in hypertriglyceridemic men.Effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia.Kiwifruit consumption favourably affects plasma lipids in a randomised controlled trial in hypercholesterolaemic men.
P2860
Q24795932-A7DF39BF-EFC8-4FAE-AAD6-66F4ABD494F5Q26824004-A549F651-07E6-4FD0-9883-0BB929A4DC68Q28116206-856C1262-638F-464F-A139-4C578C301248Q28220294-A81547A2-EEE9-4DED-99F8-FC21F6DD30BEQ33814212-0B87C863-2EA6-4903-A5F7-1E4FF80CCD7FQ34220871-D255AAF4-0E23-4606-AB2D-FD7CB73A26FEQ34256139-A732318B-E337-4DD0-AA4E-3B0DFA4AFF06Q35607772-FE0B9655-B602-4927-BFE4-02E1FA8D1554Q35740502-D83710E2-861F-456D-9420-E4ADD4191BABQ35796991-119A4CE4-6A1A-478D-B8D5-2CCD9B746587Q35797050-8F24ED5B-156E-4E4F-B878-30E3F70D3024Q35904110-74030E99-FC32-4368-BA0C-C5AD479D2C0EQ35945864-74C851C8-7A2B-4642-8CE5-101D43DD4035Q36012834-D281C30F-CB4B-4010-8B98-C3D713311473Q36197671-A7842148-217B-498A-A34C-D6CD10AF520CQ36462080-97A0536F-A3C3-46E5-834E-2BC218326538Q36473656-B3AFC129-08EF-46A9-B995-9131CF53B344Q36487064-AD2A7F19-6B3E-4FA9-98F6-BCE862C96800Q36544924-FF5D32F0-839D-4B54-91F1-311C520B076DQ36745091-B9E63F1C-E4DC-489B-B615-FBF894EF6A0AQ36966320-627BF4EA-AF2B-44BE-8994-B4E6DDADFC04Q37176924-30E25D67-D8FF-4C0B-83CC-93C03E283574Q37222656-E0B32789-B389-4847-89F1-2882C7A792B4Q37358489-AAE1E55A-722F-40B3-9216-C993ABF8DEEFQ37434362-62935690-27B8-49F1-BF44-9E51FCF38B14Q37719160-4C3F98B7-9F25-460F-96AC-C2B68A8AC6FAQ37772510-1E952540-472E-46C8-8763-C223801100C6Q38089776-6C1D227E-A198-4F28-BA58-B4C5542A6EDAQ38543425-F7DFC52A-37F4-4E6D-9F8E-19DFDC4BEC2DQ42655863-DCF9CEEC-8CCE-497E-B328-F3B245254018Q44127677-05066639-F355-4048-899B-1EDD89679C42Q44360339-89D7935F-144A-43CF-B8D9-CBB8949A2AD1Q44605265-FC0B7081-F687-47E3-A7C0-DA3B8E3C0C40Q44819479-D1A4166A-F85A-4AB9-8DEA-7CD960A21870Q44845872-382D3221-BA5E-4163-838A-3C209EEAD91EQ44919539-EE190400-619D-4D73-966C-2FC9194B5ED1Q44940767-AD5142CF-B98B-4909-93AF-C01EFA164193Q45126818-A82FF480-AC46-4911-9E55-FD1C9382FC9AQ45148138-079D8716-E216-40D2-87FF-22CC5167BC55Q46382295-A0815C70-1D8D-4379-82EF-3D5418280659
P2860
HDL metabolism in hypertriglyceridemic states: an overview.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
HDL metabolism in hypertriglyceridemic states: an overview.
@ast
HDL metabolism in hypertriglyceridemic states: an overview.
@en
type
label
HDL metabolism in hypertriglyceridemic states: an overview.
@ast
HDL metabolism in hypertriglyceridemic states: an overview.
@en
prefLabel
HDL metabolism in hypertriglyceridemic states: an overview.
@ast
HDL metabolism in hypertriglyceridemic states: an overview.
@en
P2093
P1433
P1476
HDL metabolism in hypertriglyceridemic states: an overview.
@en
P2093
P304
P356
10.1016/S0009-8981(99)00098-4
P577
1999-08-01T00:00:00Z